2855. Respiratory Syncytial Virus Neutralizing Antibodies in Cord Blood and Serum from Infants up to 2 Years of Age in a Multinational Prospective Study Article Swipe
Joseph B. Domachowske
,
Véronique Bianco
,
Ana Ceballos
,
Luis Cousin
,
Ulises D’Andrea
,
Ilse Dieussaert
,
Janet A. Englund
,
Sanjay Gandhi
,
Gerco Haars
,
Lisa Jose
,
Nicola P. Klein
,
Joanne M. Langley
,
Amanda Leach
,
Shabir A. Madhi
,
Koen Maleux
,
Thi Lien-Anh Nguyên
,
Thanyawee Puthanakit
,
Peter Silas
,
Sonia Stoszek
,
Auchara Tangsathapornpong
,
Jamaree Teeratakulpisarn
,
Miia Virta
,
Khalequ Zaman
·
YOU?
·
· 2019
· Open Access
·
· DOI: https://doi.org/10.1093/ofid/ofz359.160
YOU?
·
· 2019
· Open Access
·
· DOI: https://doi.org/10.1093/ofid/ofz359.160
Background Respiratory syncytial virus (RSV) is the most common cause of lower respiratory tract infections (LRTI) during infancy worldwide. High cord blood (CB) concentrations of anti-RSV neutralizing antibody (nAb) may attenuate, delay, or prevent infant infection. We report RSV A and B nAb concentrations in CB and serum from a birth cohort at different time points through 2 years of age. Methods Between 2013 and 2017, newborns from 8 countries were studied prospectively from birth to 2 years of age (NCT01995175). CB was collected at birth for the entire cohort. A subcohort of children was randomly assigned to have one blood sample collected again at either 2, 4, 6, 12, 18, or 24 months of age. Sera were analyzed for RSV A and B nAb concentrations by serum neutralization assay. Active surveillance was used to identify LRTIs during the 2-year follow-up as previously reported. Results In total, 2,401 newborns were enrolled and followed up. >99% of infants had detectable CB RSV A and B nAb. Geometric mean antibody titers (GMTs) varied by country, but were overall higher for RSV B than for RSV A (327 vs. 251; Figure 1). The lowest GMTs were seen from CB sera collected from South African newborns (197 RSV A, 255 RSV B); Canadian newborns had the highest RSV A GMT (383), while Hondurans had the highest RSV B GMT (460). 1380 infants provided follow-up serum nAb results as part of the subcohort (Figure 2). Dramatic waning of GMTs was evident, with a ~3-fold drop in GMTs at 2 months of age, and an additional ~2-fold drop between 2 and 4 months of age. At 6 and 12 months of age, 71% and 50% of infants had RSV A nAb and GMTs were at a nadir of 14. At 6, 12, and 18 months of age, RSV B nAb was detected in 98%, 69%, and 63% of infants, respectively. The RSV B nAb nadir GMT of 20 was observed at 12 months of age, while the 6- and 18-month RSV B nAb GMTs were 30 and 31, respectively. A total of 1,017 LRTIs were identified during the 2-year study period; of which, 94 (9%) were caused by RSV A and 132 (13%) by RSV B. Associations between CB nAb levels and RSV infection will be presented. Conclusion Neutralizing Ab to RSV A and B was present at birth in infants from 8 countries, and waned over time. GMTs were at a nadir at 6 to 12 months of age. Funding. GlaxoSmithKline Biologicals SA. Disclosures All Authors: No reported Disclosures.
Related Topics
Concepts
Medicine
Cord blood
Cohort
Titer
Prospective cohort study
Lower respiratory tract infection
Antibody
Pediatrics
Neutralizing antibody
Respiratory system
Immunology
Respiratory tract infections
Internal medicine
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1093/ofid/ofz359.160
- https://academic.oup.com/ofid/article-pdf/6/Supplement_2/S74/30274313/ofz359.160.pdf
- OA Status
- gold
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W2981813447
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W2981813447Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1093/ofid/ofz359.160Digital Object Identifier
- Title
-
2855. Respiratory Syncytial Virus Neutralizing Antibodies in Cord Blood and Serum from Infants up to 2 Years of Age in a Multinational Prospective StudyWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2019Year of publication
- Publication date
-
2019-10-01Full publication date if available
- Authors
-
Joseph B. Domachowske, Véronique Bianco, Ana Ceballos, Luis Cousin, Ulises D’Andrea, Ilse Dieussaert, Janet A. Englund, Sanjay Gandhi, Gerco Haars, Lisa Jose, Nicola P. Klein, Joanne M. Langley, Amanda Leach, Shabir A. Madhi, Koen Maleux, Thi Lien-Anh Nguyên, Thanyawee Puthanakit, Peter Silas, Sonia Stoszek, Auchara Tangsathapornpong, Jamaree Teeratakulpisarn, Miia Virta, Khalequ ZamanList of authors in order
- Landing page
-
https://doi.org/10.1093/ofid/ofz359.160Publisher landing page
- PDF URL
-
https://academic.oup.com/ofid/article-pdf/6/Supplement_2/S74/30274313/ofz359.160.pdfDirect link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://academic.oup.com/ofid/article-pdf/6/Supplement_2/S74/30274313/ofz359.160.pdfDirect OA link when available
- Concepts
-
Medicine, Cord blood, Cohort, Titer, Prospective cohort study, Lower respiratory tract infection, Antibody, Pediatrics, Neutralizing antibody, Respiratory system, Immunology, Respiratory tract infections, Internal medicineTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
0Total citation count in OpenAlex
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W2981813447 |
|---|---|
| doi | https://doi.org/10.1093/ofid/ofz359.160 |
| ids.doi | https://doi.org/10.1093/ofid/ofz359.160 |
| ids.mag | 2981813447 |
| ids.openalex | https://openalex.org/W2981813447 |
| fwci | 0.0 |
| type | article |
| title | 2855. Respiratory Syncytial Virus Neutralizing Antibodies in Cord Blood and Serum from Infants up to 2 Years of Age in a Multinational Prospective Study |
| biblio.issue | Supplement_2 |
| biblio.volume | 6 |
| biblio.last_page | S75 |
| biblio.first_page | S74 |
| topics[0].id | https://openalex.org/T11243 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9998000264167786 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2713 |
| topics[0].subfield.display_name | Epidemiology |
| topics[0].display_name | Respiratory viral infections research |
| topics[1].id | https://openalex.org/T11586 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9916999936103821 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2746 |
| topics[1].subfield.display_name | Surgery |
| topics[1].display_name | Congenital Diaphragmatic Hernia Studies |
| topics[2].id | https://openalex.org/T10549 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9872999787330627 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2740 |
| topics[2].subfield.display_name | Pulmonary and Respiratory Medicine |
| topics[2].display_name | Neonatal Respiratory Health Research |
| is_xpac | False |
| apc_list.value | 3064 |
| apc_list.currency | USD |
| apc_list.value_usd | 3064 |
| apc_paid.value | 3064 |
| apc_paid.currency | USD |
| apc_paid.value_usd | 3064 |
| concepts[0].id | https://openalex.org/C71924100 |
| concepts[0].level | 0 |
| concepts[0].score | 0.9127945899963379 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[0].display_name | Medicine |
| concepts[1].id | https://openalex.org/C2780914630 |
| concepts[1].level | 2 |
| concepts[1].score | 0.731621265411377 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q914952 |
| concepts[1].display_name | Cord blood |
| concepts[2].id | https://openalex.org/C72563966 |
| concepts[2].level | 2 |
| concepts[2].score | 0.5545343160629272 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q1303415 |
| concepts[2].display_name | Cohort |
| concepts[3].id | https://openalex.org/C32611913 |
| concepts[3].level | 3 |
| concepts[3].score | 0.547071099281311 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q2166189 |
| concepts[3].display_name | Titer |
| concepts[4].id | https://openalex.org/C188816634 |
| concepts[4].level | 2 |
| concepts[4].score | 0.5004281997680664 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q2113324 |
| concepts[4].display_name | Prospective cohort study |
| concepts[5].id | https://openalex.org/C2776399701 |
| concepts[5].level | 4 |
| concepts[5].score | 0.4999542236328125 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q3631290 |
| concepts[5].display_name | Lower respiratory tract infection |
| concepts[6].id | https://openalex.org/C159654299 |
| concepts[6].level | 2 |
| concepts[6].score | 0.4952448904514313 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q79460 |
| concepts[6].display_name | Antibody |
| concepts[7].id | https://openalex.org/C187212893 |
| concepts[7].level | 1 |
| concepts[7].score | 0.47938302159309387 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q123028 |
| concepts[7].display_name | Pediatrics |
| concepts[8].id | https://openalex.org/C2779261636 |
| concepts[8].level | 3 |
| concepts[8].score | 0.4500744640827179 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q7003054 |
| concepts[8].display_name | Neutralizing antibody |
| concepts[9].id | https://openalex.org/C534529494 |
| concepts[9].level | 2 |
| concepts[9].score | 0.432100385427475 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q7891 |
| concepts[9].display_name | Respiratory system |
| concepts[10].id | https://openalex.org/C203014093 |
| concepts[10].level | 1 |
| concepts[10].score | 0.4052726626396179 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q101929 |
| concepts[10].display_name | Immunology |
| concepts[11].id | https://openalex.org/C2776012195 |
| concepts[11].level | 3 |
| concepts[11].score | 0.37481218576431274 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q754447 |
| concepts[11].display_name | Respiratory tract infections |
| concepts[12].id | https://openalex.org/C126322002 |
| concepts[12].level | 1 |
| concepts[12].score | 0.22984939813613892 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[12].display_name | Internal medicine |
| keywords[0].id | https://openalex.org/keywords/medicine |
| keywords[0].score | 0.9127945899963379 |
| keywords[0].display_name | Medicine |
| keywords[1].id | https://openalex.org/keywords/cord-blood |
| keywords[1].score | 0.731621265411377 |
| keywords[1].display_name | Cord blood |
| keywords[2].id | https://openalex.org/keywords/cohort |
| keywords[2].score | 0.5545343160629272 |
| keywords[2].display_name | Cohort |
| keywords[3].id | https://openalex.org/keywords/titer |
| keywords[3].score | 0.547071099281311 |
| keywords[3].display_name | Titer |
| keywords[4].id | https://openalex.org/keywords/prospective-cohort-study |
| keywords[4].score | 0.5004281997680664 |
| keywords[4].display_name | Prospective cohort study |
| keywords[5].id | https://openalex.org/keywords/lower-respiratory-tract-infection |
| keywords[5].score | 0.4999542236328125 |
| keywords[5].display_name | Lower respiratory tract infection |
| keywords[6].id | https://openalex.org/keywords/antibody |
| keywords[6].score | 0.4952448904514313 |
| keywords[6].display_name | Antibody |
| keywords[7].id | https://openalex.org/keywords/pediatrics |
| keywords[7].score | 0.47938302159309387 |
| keywords[7].display_name | Pediatrics |
| keywords[8].id | https://openalex.org/keywords/neutralizing-antibody |
| keywords[8].score | 0.4500744640827179 |
| keywords[8].display_name | Neutralizing antibody |
| keywords[9].id | https://openalex.org/keywords/respiratory-system |
| keywords[9].score | 0.432100385427475 |
| keywords[9].display_name | Respiratory system |
| keywords[10].id | https://openalex.org/keywords/immunology |
| keywords[10].score | 0.4052726626396179 |
| keywords[10].display_name | Immunology |
| keywords[11].id | https://openalex.org/keywords/respiratory-tract-infections |
| keywords[11].score | 0.37481218576431274 |
| keywords[11].display_name | Respiratory tract infections |
| keywords[12].id | https://openalex.org/keywords/internal-medicine |
| keywords[12].score | 0.22984939813613892 |
| keywords[12].display_name | Internal medicine |
| language | en |
| locations[0].id | doi:10.1093/ofid/ofz359.160 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S2735126445 |
| locations[0].source.issn | 2328-8957 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | True |
| locations[0].source.issn_l | 2328-8957 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | True |
| locations[0].source.display_name | Open Forum Infectious Diseases |
| locations[0].source.host_organization | https://openalex.org/P4310311648 |
| locations[0].source.host_organization_name | Oxford University Press |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310311648, https://openalex.org/P4310311647 |
| locations[0].source.host_organization_lineage_names | Oxford University Press, University of Oxford |
| locations[0].license | cc-by-nc-nd |
| locations[0].pdf_url | https://academic.oup.com/ofid/article-pdf/6/Supplement_2/S74/30274313/ofz359.160.pdf |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by-nc-nd |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Open Forum Infectious Diseases |
| locations[0].landing_page_url | https://doi.org/10.1093/ofid/ofz359.160 |
| locations[1].id | pmh:oai:pubmedcentral.nih.gov:6808773 |
| locations[1].is_oa | True |
| locations[1].source.id | https://openalex.org/S2764455111 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed Central |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | submittedVersion |
| locations[1].raw_type | Text |
| locations[1].license_id | |
| locations[1].is_accepted | False |
| locations[1].is_published | False |
| locations[1].raw_source_name | Open Forum Infect Dis |
| locations[1].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/6808773 |
| indexed_in | crossref, doaj |
| authorships[0].author.id | https://openalex.org/A5065385960 |
| authorships[0].author.orcid | https://orcid.org/0000-0003-1510-1309 |
| authorships[0].author.display_name | Joseph B. Domachowske |
| authorships[0].countries | US |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I20388574 |
| authorships[0].affiliations[0].raw_affiliation_string | SUNY Upstate Medical University, Syracuse, New York |
| authorships[0].institutions[0].id | https://openalex.org/I20388574 |
| authorships[0].institutions[0].ror | https://ror.org/040kfrw16 |
| authorships[0].institutions[0].type | education |
| authorships[0].institutions[0].lineage | https://openalex.org/I20388574 |
| authorships[0].institutions[0].country_code | US |
| authorships[0].institutions[0].display_name | SUNY Upstate Medical University |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Joseph B Domachowske |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | SUNY Upstate Medical University, Syracuse, New York |
| authorships[1].author.id | https://openalex.org/A5067123101 |
| authorships[1].author.orcid | https://orcid.org/0009-0005-0554-2663 |
| authorships[1].author.display_name | Véronique Bianco |
| authorships[1].countries | US |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I4210114143 |
| authorships[1].affiliations[0].raw_affiliation_string | GSK, Rockville, Maryland |
| authorships[1].institutions[0].id | https://openalex.org/I4210114143 |
| authorships[1].institutions[0].ror | https://ror.org/025vn3989 |
| authorships[1].institutions[0].type | company |
| authorships[1].institutions[0].lineage | https://openalex.org/I188950975, https://openalex.org/I4210114143 |
| authorships[1].institutions[0].country_code | US |
| authorships[1].institutions[0].display_name | GlaxoSmithKline (United States) |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Veronique Bianco |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | GSK, Rockville, Maryland |
| authorships[2].author.id | https://openalex.org/A5011949298 |
| authorships[2].author.orcid | https://orcid.org/0000-0003-4564-7361 |
| authorships[2].author.display_name | Ana Ceballos |
| authorships[2].countries | AR |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I4210151630 |
| authorships[2].affiliations[0].raw_affiliation_string | Instituto Medico Rio Cuarto, Río Cuarto, Cordoba, Argentina |
| authorships[2].institutions[0].id | https://openalex.org/I4210151630 |
| authorships[2].institutions[0].ror | https://ror.org/05v9dz963 |
| authorships[2].institutions[0].type | healthcare |
| authorships[2].institutions[0].lineage | https://openalex.org/I4210151630 |
| authorships[2].institutions[0].country_code | AR |
| authorships[2].institutions[0].display_name | Instituto Médico Río Cuarto |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Ana Ceballos |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Instituto Medico Rio Cuarto, Río Cuarto, Cordoba, Argentina |
| authorships[3].author.id | https://openalex.org/A5047464286 |
| authorships[3].author.orcid | |
| authorships[3].author.display_name | Luis Cousin |
| authorships[3].countries | HN |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I4210148467 |
| authorships[3].affiliations[0].raw_affiliation_string | Tecnologia en Investigación, San Pedro Sula, Cortes, Honduras |
| authorships[3].institutions[0].id | https://openalex.org/I4210148467 |
| authorships[3].institutions[0].ror | https://ror.org/05sve0f84 |
| authorships[3].institutions[0].type | nonprofit |
| authorships[3].institutions[0].lineage | https://openalex.org/I4210148467 |
| authorships[3].institutions[0].country_code | HN |
| authorships[3].institutions[0].display_name | Honduras Foundation for Agricultural Research |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Luis Cousin |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Tecnologia en Investigación, San Pedro Sula, Cortes, Honduras |
| authorships[4].author.id | https://openalex.org/A5041433516 |
| authorships[4].author.orcid | |
| authorships[4].author.display_name | Ulises D’Andrea |
| authorships[4].countries | AR |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I4210151630 |
| authorships[4].affiliations[0].raw_affiliation_string | Instituto Medico Rio Cuarto, Río Cuarto, Cordoba, Argentina |
| authorships[4].institutions[0].id | https://openalex.org/I4210151630 |
| authorships[4].institutions[0].ror | https://ror.org/05v9dz963 |
| authorships[4].institutions[0].type | healthcare |
| authorships[4].institutions[0].lineage | https://openalex.org/I4210151630 |
| authorships[4].institutions[0].country_code | AR |
| authorships[4].institutions[0].display_name | Instituto Médico Río Cuarto |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Ulises D’Andrea |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Instituto Medico Rio Cuarto, Río Cuarto, Cordoba, Argentina |
| authorships[5].author.id | https://openalex.org/A5057302487 |
| authorships[5].author.orcid | https://orcid.org/0000-0001-8158-8819 |
| authorships[5].author.display_name | Ilse Dieussaert |
| authorships[5].countries | US |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I4210114143 |
| authorships[5].affiliations[0].raw_affiliation_string | GSK, Rockville, Maryland |
| authorships[5].institutions[0].id | https://openalex.org/I4210114143 |
| authorships[5].institutions[0].ror | https://ror.org/025vn3989 |
| authorships[5].institutions[0].type | company |
| authorships[5].institutions[0].lineage | https://openalex.org/I188950975, https://openalex.org/I4210114143 |
| authorships[5].institutions[0].country_code | US |
| authorships[5].institutions[0].display_name | GlaxoSmithKline (United States) |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Ilse Dieussaert |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | GSK, Rockville, Maryland |
| authorships[6].author.id | https://openalex.org/A5070328573 |
| authorships[6].author.orcid | https://orcid.org/0000-0003-1134-4178 |
| authorships[6].author.display_name | Janet A. Englund |
| authorships[6].countries | US |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I1295499534, https://openalex.org/I201448701 |
| authorships[6].affiliations[0].raw_affiliation_string | Seattle Children’s Hospital/University of Washington, Seattle, Washington |
| authorships[6].institutions[0].id | https://openalex.org/I1295499534 |
| authorships[6].institutions[0].ror | https://ror.org/01njes783 |
| authorships[6].institutions[0].type | healthcare |
| authorships[6].institutions[0].lineage | https://openalex.org/I1295499534 |
| authorships[6].institutions[0].country_code | US |
| authorships[6].institutions[0].display_name | Seattle Children's Hospital |
| authorships[6].institutions[1].id | https://openalex.org/I201448701 |
| authorships[6].institutions[1].ror | https://ror.org/00cvxb145 |
| authorships[6].institutions[1].type | education |
| authorships[6].institutions[1].lineage | https://openalex.org/I201448701 |
| authorships[6].institutions[1].country_code | US |
| authorships[6].institutions[1].display_name | University of Washington |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Janet A Englund |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | Seattle Children’s Hospital/University of Washington, Seattle, Washington |
| authorships[7].author.id | https://openalex.org/A5110160087 |
| authorships[7].author.orcid | https://orcid.org/0009-0006-6862-5850 |
| authorships[7].author.display_name | Sanjay Gandhi |
| authorships[7].countries | US |
| authorships[7].affiliations[0].institution_ids | https://openalex.org/I4210114143 |
| authorships[7].affiliations[0].raw_affiliation_string | GSK, Rockville, Maryland |
| authorships[7].institutions[0].id | https://openalex.org/I4210114143 |
| authorships[7].institutions[0].ror | https://ror.org/025vn3989 |
| authorships[7].institutions[0].type | company |
| authorships[7].institutions[0].lineage | https://openalex.org/I188950975, https://openalex.org/I4210114143 |
| authorships[7].institutions[0].country_code | US |
| authorships[7].institutions[0].display_name | GlaxoSmithKline (United States) |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Sanjay Gandhi |
| authorships[7].is_corresponding | False |
| authorships[7].raw_affiliation_strings | GSK, Rockville, Maryland |
| authorships[8].author.id | https://openalex.org/A5071792225 |
| authorships[8].author.orcid | |
| authorships[8].author.display_name | Gerco Haars |
| authorships[8].countries | US |
| authorships[8].affiliations[0].institution_ids | https://openalex.org/I4210114143 |
| authorships[8].affiliations[0].raw_affiliation_string | GSK, Rockville, Maryland |
| authorships[8].institutions[0].id | https://openalex.org/I4210114143 |
| authorships[8].institutions[0].ror | https://ror.org/025vn3989 |
| authorships[8].institutions[0].type | company |
| authorships[8].institutions[0].lineage | https://openalex.org/I188950975, https://openalex.org/I4210114143 |
| authorships[8].institutions[0].country_code | US |
| authorships[8].institutions[0].display_name | GlaxoSmithKline (United States) |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Gerco Haars |
| authorships[8].is_corresponding | False |
| authorships[8].raw_affiliation_strings | GSK, Rockville, Maryland |
| authorships[9].author.id | https://openalex.org/A5067329446 |
| authorships[9].author.orcid | |
| authorships[9].author.display_name | Lisa Jose |
| authorships[9].countries | ZA |
| authorships[9].affiliations[0].institution_ids | https://openalex.org/I192619145 |
| authorships[9].affiliations[0].raw_affiliation_string | Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, Gauteng, South Africa |
| authorships[9].institutions[0].id | https://openalex.org/I192619145 |
| authorships[9].institutions[0].ror | https://ror.org/03rp50x72 |
| authorships[9].institutions[0].type | education |
| authorships[9].institutions[0].lineage | https://openalex.org/I192619145 |
| authorships[9].institutions[0].country_code | ZA |
| authorships[9].institutions[0].display_name | University of the Witwatersrand |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | Lisa Jose |
| authorships[9].is_corresponding | False |
| authorships[9].raw_affiliation_strings | Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, Gauteng, South Africa |
| authorships[10].author.id | https://openalex.org/A5034478332 |
| authorships[10].author.orcid | https://orcid.org/0000-0003-1777-4814 |
| authorships[10].author.display_name | Nicola P. Klein |
| authorships[10].countries | US |
| authorships[10].affiliations[0].institution_ids | https://openalex.org/I1343052199 |
| authorships[10].affiliations[0].raw_affiliation_string | Kaiser Permanente Northern California, Oakland, California |
| authorships[10].institutions[0].id | https://openalex.org/I1343052199 |
| authorships[10].institutions[0].ror | https://ror.org/00t60zh31 |
| authorships[10].institutions[0].type | nonprofit |
| authorships[10].institutions[0].lineage | https://openalex.org/I1343052199 |
| authorships[10].institutions[0].country_code | US |
| authorships[10].institutions[0].display_name | Kaiser Permanente |
| authorships[10].author_position | middle |
| authorships[10].raw_author_name | Nicola Klein |
| authorships[10].is_corresponding | False |
| authorships[10].raw_affiliation_strings | Kaiser Permanente Northern California, Oakland, California |
| authorships[11].author.id | https://openalex.org/A5091332556 |
| authorships[11].author.orcid | https://orcid.org/0000-0003-3270-7345 |
| authorships[11].author.display_name | Joanne M. Langley |
| authorships[11].countries | CA |
| authorships[11].affiliations[0].institution_ids | https://openalex.org/I129902397, https://openalex.org/I2800394539, https://openalex.org/I2802394193 |
| authorships[11].affiliations[0].raw_affiliation_string | Canadian Center for Vaccinology (Dalhousie University, IWK Health Centre and Nova Scotia Health Authority), Halifax, NS, Canada |
| authorships[11].institutions[0].id | https://openalex.org/I129902397 |
| authorships[11].institutions[0].ror | https://ror.org/01e6qks80 |
| authorships[11].institutions[0].type | education |
| authorships[11].institutions[0].lineage | https://openalex.org/I129902397 |
| authorships[11].institutions[0].country_code | CA |
| authorships[11].institutions[0].display_name | Dalhousie University |
| authorships[11].institutions[1].id | https://openalex.org/I2800394539 |
| authorships[11].institutions[1].ror | https://ror.org/0064zg438 |
| authorships[11].institutions[1].type | healthcare |
| authorships[11].institutions[1].lineage | https://openalex.org/I2800394539 |
| authorships[11].institutions[1].country_code | CA |
| authorships[11].institutions[1].display_name | Izaak Walton Killam Health Centre |
| authorships[11].institutions[2].id | https://openalex.org/I2802394193 |
| authorships[11].institutions[2].ror | https://ror.org/035gna214 |
| authorships[11].institutions[2].type | government |
| authorships[11].institutions[2].lineage | https://openalex.org/I2802394193 |
| authorships[11].institutions[2].country_code | CA |
| authorships[11].institutions[2].display_name | Nova Scotia Health Authority |
| authorships[11].author_position | middle |
| authorships[11].raw_author_name | Joanne Marie. Langley |
| authorships[11].is_corresponding | False |
| authorships[11].raw_affiliation_strings | Canadian Center for Vaccinology (Dalhousie University, IWK Health Centre and Nova Scotia Health Authority), Halifax, NS, Canada |
| authorships[12].author.id | https://openalex.org/A5061884440 |
| authorships[12].author.orcid | https://orcid.org/0000-0002-4638-8392 |
| authorships[12].author.display_name | Amanda Leach |
| authorships[12].countries | US |
| authorships[12].affiliations[0].institution_ids | https://openalex.org/I4210114143 |
| authorships[12].affiliations[0].raw_affiliation_string | GSK, Rockville, Maryland |
| authorships[12].institutions[0].id | https://openalex.org/I4210114143 |
| authorships[12].institutions[0].ror | https://ror.org/025vn3989 |
| authorships[12].institutions[0].type | company |
| authorships[12].institutions[0].lineage | https://openalex.org/I188950975, https://openalex.org/I4210114143 |
| authorships[12].institutions[0].country_code | US |
| authorships[12].institutions[0].display_name | GlaxoSmithKline (United States) |
| authorships[12].author_position | middle |
| authorships[12].raw_author_name | Amanda Leach |
| authorships[12].is_corresponding | False |
| authorships[12].raw_affiliation_strings | GSK, Rockville, Maryland |
| authorships[13].author.id | https://openalex.org/A5071188493 |
| authorships[13].author.orcid | https://orcid.org/0000-0002-7629-0636 |
| authorships[13].author.display_name | Shabir A. Madhi |
| authorships[13].countries | ZA |
| authorships[13].affiliations[0].institution_ids | https://openalex.org/I192619145 |
| authorships[13].affiliations[0].raw_affiliation_string | Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, Gauteng, South Africa |
| authorships[13].institutions[0].id | https://openalex.org/I192619145 |
| authorships[13].institutions[0].ror | https://ror.org/03rp50x72 |
| authorships[13].institutions[0].type | education |
| authorships[13].institutions[0].lineage | https://openalex.org/I192619145 |
| authorships[13].institutions[0].country_code | ZA |
| authorships[13].institutions[0].display_name | University of the Witwatersrand |
| authorships[13].author_position | middle |
| authorships[13].raw_author_name | Shabir A Madhi |
| authorships[13].is_corresponding | False |
| authorships[13].raw_affiliation_strings | Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, Gauteng, South Africa |
| authorships[14].author.id | https://openalex.org/A5037505702 |
| authorships[14].author.orcid | https://orcid.org/0000-0002-6015-5309 |
| authorships[14].author.display_name | Koen Maleux |
| authorships[14].countries | US |
| authorships[14].affiliations[0].institution_ids | https://openalex.org/I4210114143 |
| authorships[14].affiliations[0].raw_affiliation_string | GSK, Rockville, Maryland |
| authorships[14].institutions[0].id | https://openalex.org/I4210114143 |
| authorships[14].institutions[0].ror | https://ror.org/025vn3989 |
| authorships[14].institutions[0].type | company |
| authorships[14].institutions[0].lineage | https://openalex.org/I188950975, https://openalex.org/I4210114143 |
| authorships[14].institutions[0].country_code | US |
| authorships[14].institutions[0].display_name | GlaxoSmithKline (United States) |
| authorships[14].author_position | middle |
| authorships[14].raw_author_name | Koen Maleux |
| authorships[14].is_corresponding | False |
| authorships[14].raw_affiliation_strings | GSK, Rockville, Maryland |
| authorships[15].author.id | https://openalex.org/A5111385838 |
| authorships[15].author.orcid | |
| authorships[15].author.display_name | Thi Lien-Anh Nguyên |
| authorships[15].countries | US |
| authorships[15].affiliations[0].institution_ids | https://openalex.org/I4210114143 |
| authorships[15].affiliations[0].raw_affiliation_string | GSK, Rockville, Maryland |
| authorships[15].institutions[0].id | https://openalex.org/I4210114143 |
| authorships[15].institutions[0].ror | https://ror.org/025vn3989 |
| authorships[15].institutions[0].type | company |
| authorships[15].institutions[0].lineage | https://openalex.org/I188950975, https://openalex.org/I4210114143 |
| authorships[15].institutions[0].country_code | US |
| authorships[15].institutions[0].display_name | GlaxoSmithKline (United States) |
| authorships[15].author_position | middle |
| authorships[15].raw_author_name | Thi Lien-Anh Nguyen |
| authorships[15].is_corresponding | False |
| authorships[15].raw_affiliation_strings | GSK, Rockville, Maryland |
| authorships[16].author.id | https://openalex.org/A5051559120 |
| authorships[16].author.orcid | https://orcid.org/0000-0003-1873-1867 |
| authorships[16].author.display_name | Thanyawee Puthanakit |
| authorships[16].countries | TH |
| authorships[16].affiliations[0].institution_ids | https://openalex.org/I158708052 |
| authorships[16].affiliations[0].raw_affiliation_string | Faculty of Medicine, Chulalongkorn University, Bangkok, Krung Thep, Thailand |
| authorships[16].institutions[0].id | https://openalex.org/I158708052 |
| authorships[16].institutions[0].ror | https://ror.org/028wp3y58 |
| authorships[16].institutions[0].type | education |
| authorships[16].institutions[0].lineage | https://openalex.org/I158708052 |
| authorships[16].institutions[0].country_code | TH |
| authorships[16].institutions[0].display_name | Chulalongkorn University |
| authorships[16].author_position | middle |
| authorships[16].raw_author_name | Thanyawee Puthanakit |
| authorships[16].is_corresponding | False |
| authorships[16].raw_affiliation_strings | Faculty of Medicine, Chulalongkorn University, Bangkok, Krung Thep, Thailand |
| authorships[17].author.id | https://openalex.org/A5011165216 |
| authorships[17].author.orcid | https://orcid.org/0000-0003-0980-0701 |
| authorships[17].author.display_name | Peter Silas |
| authorships[17].affiliations[0].raw_affiliation_string | Wee Care Pediatrics, Syracuse, Utah |
| authorships[17].author_position | middle |
| authorships[17].raw_author_name | Peter Silas |
| authorships[17].is_corresponding | False |
| authorships[17].raw_affiliation_strings | Wee Care Pediatrics, Syracuse, Utah |
| authorships[18].author.id | https://openalex.org/A5003192771 |
| authorships[18].author.orcid | |
| authorships[18].author.display_name | Sonia Stoszek |
| authorships[18].countries | US |
| authorships[18].affiliations[0].institution_ids | https://openalex.org/I4210114143 |
| authorships[18].affiliations[0].raw_affiliation_string | GSK, Rockville, Maryland |
| authorships[18].institutions[0].id | https://openalex.org/I4210114143 |
| authorships[18].institutions[0].ror | https://ror.org/025vn3989 |
| authorships[18].institutions[0].type | company |
| authorships[18].institutions[0].lineage | https://openalex.org/I188950975, https://openalex.org/I4210114143 |
| authorships[18].institutions[0].country_code | US |
| authorships[18].institutions[0].display_name | GlaxoSmithKline (United States) |
| authorships[18].author_position | middle |
| authorships[18].raw_author_name | Sonia K Stoszek |
| authorships[18].is_corresponding | False |
| authorships[18].raw_affiliation_strings | GSK, Rockville, Maryland |
| authorships[19].author.id | https://openalex.org/A5025633275 |
| authorships[19].author.orcid | https://orcid.org/0000-0001-7715-8744 |
| authorships[19].author.display_name | Auchara Tangsathapornpong |
| authorships[19].countries | TH |
| authorships[19].affiliations[0].institution_ids | https://openalex.org/I108108428 |
| authorships[19].affiliations[0].raw_affiliation_string | Faculty of Medicine, Thammasat University, Pathum Thani, Pathum Thani, Thailand |
| authorships[19].institutions[0].id | https://openalex.org/I108108428 |
| authorships[19].institutions[0].ror | https://ror.org/002yp7f20 |
| authorships[19].institutions[0].type | education |
| authorships[19].institutions[0].lineage | https://openalex.org/I108108428 |
| authorships[19].institutions[0].country_code | TH |
| authorships[19].institutions[0].display_name | Thammasat University |
| authorships[19].author_position | middle |
| authorships[19].raw_author_name | Auchara Tangsathapornpong |
| authorships[19].is_corresponding | False |
| authorships[19].raw_affiliation_strings | Faculty of Medicine, Thammasat University, Pathum Thani, Pathum Thani, Thailand |
| authorships[20].author.id | https://openalex.org/A5029310736 |
| authorships[20].author.orcid | |
| authorships[20].author.display_name | Jamaree Teeratakulpisarn |
| authorships[20].countries | TH |
| authorships[20].affiliations[0].institution_ids | https://openalex.org/I179193067 |
| authorships[20].affiliations[0].raw_affiliation_string | Khon Kaen University, Khon Kaen, Thailand |
| authorships[20].institutions[0].id | https://openalex.org/I179193067 |
| authorships[20].institutions[0].ror | https://ror.org/03cq4gr50 |
| authorships[20].institutions[0].type | education |
| authorships[20].institutions[0].lineage | https://openalex.org/I179193067 |
| authorships[20].institutions[0].country_code | TH |
| authorships[20].institutions[0].display_name | Khon Kaen University |
| authorships[20].author_position | middle |
| authorships[20].raw_author_name | Jamaree Teeratakulpisarn |
| authorships[20].is_corresponding | False |
| authorships[20].raw_affiliation_strings | Khon Kaen University, Khon Kaen, Thailand |
| authorships[21].author.id | https://openalex.org/A5103954851 |
| authorships[21].author.orcid | |
| authorships[21].author.display_name | Miia Virta |
| authorships[21].countries | FI |
| authorships[21].affiliations[0].institution_ids | https://openalex.org/I166825849 |
| authorships[21].affiliations[0].raw_affiliation_string | Vaccine Research Center, Tampere University, Tampere, Pirkanmaa, Finland |
| authorships[21].institutions[0].id | https://openalex.org/I166825849 |
| authorships[21].institutions[0].ror | https://ror.org/033003e23 |
| authorships[21].institutions[0].type | education |
| authorships[21].institutions[0].lineage | https://openalex.org/I166825849 |
| authorships[21].institutions[0].country_code | FI |
| authorships[21].institutions[0].display_name | Tampere University |
| authorships[21].author_position | middle |
| authorships[21].raw_author_name | Miia Virta |
| authorships[21].is_corresponding | False |
| authorships[21].raw_affiliation_strings | Vaccine Research Center, Tampere University, Tampere, Pirkanmaa, Finland |
| authorships[22].author.id | https://openalex.org/A5084092871 |
| authorships[22].author.orcid | https://orcid.org/0000-0002-1982-6879 |
| authorships[22].author.display_name | Khalequ Zaman |
| authorships[22].countries | BD |
| authorships[22].affiliations[0].institution_ids | https://openalex.org/I205889620 |
| authorships[22].affiliations[0].raw_affiliation_string | International Center for Diarrhoeal Disease Research, Dhaka, Bangladesh |
| authorships[22].institutions[0].id | https://openalex.org/I205889620 |
| authorships[22].institutions[0].ror | https://ror.org/04vsvr128 |
| authorships[22].institutions[0].type | facility |
| authorships[22].institutions[0].lineage | https://openalex.org/I205889620 |
| authorships[22].institutions[0].country_code | BD |
| authorships[22].institutions[0].display_name | International Centre for Diarrhoeal Disease Research |
| authorships[22].author_position | last |
| authorships[22].raw_author_name | Khalequ Zaman |
| authorships[22].is_corresponding | False |
| authorships[22].raw_affiliation_strings | International Center for Diarrhoeal Disease Research, Dhaka, Bangladesh |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://academic.oup.com/ofid/article-pdf/6/Supplement_2/S74/30274313/ofz359.160.pdf |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | 2855. Respiratory Syncytial Virus Neutralizing Antibodies in Cord Blood and Serum from Infants up to 2 Years of Age in a Multinational Prospective Study |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T11243 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9998000264167786 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2713 |
| primary_topic.subfield.display_name | Epidemiology |
| primary_topic.display_name | Respiratory viral infections research |
| related_works | https://openalex.org/W1991270129, https://openalex.org/W2374971639, https://openalex.org/W4223505415, https://openalex.org/W3185521317, https://openalex.org/W3204629868, https://openalex.org/W2323829501, https://openalex.org/W4313375433, https://openalex.org/W4210369265, https://openalex.org/W3088175835, https://openalex.org/W4307813351 |
| cited_by_count | 0 |
| locations_count | 2 |
| best_oa_location.id | doi:10.1093/ofid/ofz359.160 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S2735126445 |
| best_oa_location.source.issn | 2328-8957 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | True |
| best_oa_location.source.issn_l | 2328-8957 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | True |
| best_oa_location.source.display_name | Open Forum Infectious Diseases |
| best_oa_location.source.host_organization | https://openalex.org/P4310311648 |
| best_oa_location.source.host_organization_name | Oxford University Press |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310311648, https://openalex.org/P4310311647 |
| best_oa_location.source.host_organization_lineage_names | Oxford University Press, University of Oxford |
| best_oa_location.license | cc-by-nc-nd |
| best_oa_location.pdf_url | https://academic.oup.com/ofid/article-pdf/6/Supplement_2/S74/30274313/ofz359.160.pdf |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by-nc-nd |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Open Forum Infectious Diseases |
| best_oa_location.landing_page_url | https://doi.org/10.1093/ofid/ofz359.160 |
| primary_location.id | doi:10.1093/ofid/ofz359.160 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S2735126445 |
| primary_location.source.issn | 2328-8957 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | True |
| primary_location.source.issn_l | 2328-8957 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | True |
| primary_location.source.display_name | Open Forum Infectious Diseases |
| primary_location.source.host_organization | https://openalex.org/P4310311648 |
| primary_location.source.host_organization_name | Oxford University Press |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310311648, https://openalex.org/P4310311647 |
| primary_location.source.host_organization_lineage_names | Oxford University Press, University of Oxford |
| primary_location.license | cc-by-nc-nd |
| primary_location.pdf_url | https://academic.oup.com/ofid/article-pdf/6/Supplement_2/S74/30274313/ofz359.160.pdf |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by-nc-nd |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Open Forum Infectious Diseases |
| primary_location.landing_page_url | https://doi.org/10.1093/ofid/ofz359.160 |
| publication_date | 2019-10-01 |
| publication_year | 2019 |
| referenced_works_count | 0 |
| abstract_inverted_index.2 | 58, 77, 254, 264 |
| abstract_inverted_index.4 | 266 |
| abstract_inverted_index.6 | 271, 409 |
| abstract_inverted_index.8 | 69, 397 |
| abstract_inverted_index.A | 40, 91, 122, 162, 184, 215, 284, 344, 364, 387 |
| abstract_inverted_index.B | 42, 124, 164, 180, 224, 303, 317, 336, 389 |
| abstract_inverted_index.a | 50, 248, 290, 406 |
| abstract_inverted_index.12 | 273, 326, 411 |
| abstract_inverted_index.18 | 298 |
| abstract_inverted_index.2, | 107 |
| abstract_inverted_index.20 | 322 |
| abstract_inverted_index.24 | 113 |
| abstract_inverted_index.30 | 340 |
| abstract_inverted_index.4, | 108 |
| abstract_inverted_index.6, | 109, 295 |
| abstract_inverted_index.6- | 332 |
| abstract_inverted_index.94 | 358 |
| abstract_inverted_index.A, | 205 |
| abstract_inverted_index.Ab | 384 |
| abstract_inverted_index.At | 270, 294 |
| abstract_inverted_index.B. | 370 |
| abstract_inverted_index.CB | 46, 82, 160, 196, 373 |
| abstract_inverted_index.In | 146 |
| abstract_inverted_index.No | 422 |
| abstract_inverted_index.We | 37 |
| abstract_inverted_index.an | 259 |
| abstract_inverted_index.as | 142, 234 |
| abstract_inverted_index.at | 53, 85, 105, 253, 289, 325, 392, 405, 408 |
| abstract_inverted_index.be | 380 |
| abstract_inverted_index.by | 127, 172, 362, 368 |
| abstract_inverted_index.in | 45, 251, 307, 394 |
| abstract_inverted_index.is | 6 |
| abstract_inverted_index.of | 11, 25, 60, 79, 93, 115, 156, 236, 243, 256, 268, 275, 280, 292, 300, 312, 321, 328, 346, 356, 413 |
| abstract_inverted_index.or | 33, 112 |
| abstract_inverted_index.to | 76, 98, 135, 385, 410 |
| abstract_inverted_index.1). | 189 |
| abstract_inverted_index.12, | 110, 296 |
| abstract_inverted_index.132 | 366 |
| abstract_inverted_index.14. | 293 |
| abstract_inverted_index.18, | 111 |
| abstract_inverted_index.2). | 240 |
| abstract_inverted_index.255 | 206 |
| abstract_inverted_index.31, | 342 |
| abstract_inverted_index.50% | 279 |
| abstract_inverted_index.63% | 311 |
| abstract_inverted_index.71% | 277 |
| abstract_inverted_index.All | 420 |
| abstract_inverted_index.B); | 208 |
| abstract_inverted_index.GMT | 216, 225, 320 |
| abstract_inverted_index.RSV | 39, 121, 161, 179, 183, 204, 207, 214, 223, 283, 302, 316, 335, 363, 369, 377, 386 |
| abstract_inverted_index.SA. | 418 |
| abstract_inverted_index.The | 190, 315 |
| abstract_inverted_index.age | 80 |
| abstract_inverted_index.and | 41, 47, 65, 123, 152, 163, 258, 265, 272, 278, 286, 297, 310, 333, 341, 365, 376, 388, 399 |
| abstract_inverted_index.but | 174 |
| abstract_inverted_index.for | 87, 120, 178, 182 |
| abstract_inverted_index.had | 158, 211, 220, 282 |
| abstract_inverted_index.may | 30 |
| abstract_inverted_index.nAb | 43, 125, 232, 285, 304, 318, 337, 374 |
| abstract_inverted_index.one | 100 |
| abstract_inverted_index.the | 7, 88, 139, 212, 221, 237, 331, 352 |
| abstract_inverted_index.up. | 154 |
| abstract_inverted_index.vs. | 186 |
| abstract_inverted_index.was | 83, 95, 133, 245, 305, 323, 390 |
| abstract_inverted_index.(197 | 203 |
| abstract_inverted_index.(327 | 185 |
| abstract_inverted_index.(9%) | 359 |
| abstract_inverted_index.(CB) | 23 |
| abstract_inverted_index.1380 | 227 |
| abstract_inverted_index.2013 | 64 |
| abstract_inverted_index.251; | 187 |
| abstract_inverted_index.69%, | 309 |
| abstract_inverted_index.98%, | 308 |
| abstract_inverted_index.GMTs | 192, 244, 252, 287, 338, 403 |
| abstract_inverted_index.High | 20 |
| abstract_inverted_index.Sera | 117 |
| abstract_inverted_index.age, | 257, 276, 301, 329 |
| abstract_inverted_index.age. | 61, 116, 269, 414 |
| abstract_inverted_index.cord | 21 |
| abstract_inverted_index.drop | 250, 262 |
| abstract_inverted_index.from | 49, 68, 74, 195, 199, 396 |
| abstract_inverted_index.have | 99 |
| abstract_inverted_index.mean | 167 |
| abstract_inverted_index.most | 8 |
| abstract_inverted_index.nAb. | 165 |
| abstract_inverted_index.over | 401 |
| abstract_inverted_index.part | 235 |
| abstract_inverted_index.seen | 194 |
| abstract_inverted_index.sera | 197 |
| abstract_inverted_index.than | 181 |
| abstract_inverted_index.time | 55 |
| abstract_inverted_index.used | 134 |
| abstract_inverted_index.were | 71, 118, 150, 175, 193, 288, 339, 349, 360, 404 |
| abstract_inverted_index.will | 379 |
| abstract_inverted_index.with | 247 |
| abstract_inverted_index.(13%) | 367 |
| abstract_inverted_index.(RSV) | 5 |
| abstract_inverted_index.(nAb) | 29 |
| abstract_inverted_index.1,017 | 347 |
| abstract_inverted_index.2,401 | 148 |
| abstract_inverted_index.2017, | 66 |
| abstract_inverted_index.LRTIs | 137, 348 |
| abstract_inverted_index.South | 200 |
| abstract_inverted_index.again | 104 |
| abstract_inverted_index.birth | 51, 75, 86, 393 |
| abstract_inverted_index.blood | 22, 101 |
| abstract_inverted_index.cause | 10 |
| abstract_inverted_index.lower | 12 |
| abstract_inverted_index.nadir | 291, 319, 407 |
| abstract_inverted_index.serum | 48, 128, 231 |
| abstract_inverted_index.study | 354 |
| abstract_inverted_index.time. | 402 |
| abstract_inverted_index.total | 345 |
| abstract_inverted_index.tract | 14 |
| abstract_inverted_index.virus | 4 |
| abstract_inverted_index.waned | 400 |
| abstract_inverted_index.while | 218, 330 |
| abstract_inverted_index.years | 59, 78 |
| abstract_inverted_index.(383), | 217 |
| abstract_inverted_index.(460). | 226 |
| abstract_inverted_index.(GMTs) | 170 |
| abstract_inverted_index.(LRTI) | 16 |
| abstract_inverted_index.2-year | 140, 353 |
| abstract_inverted_index.Active | 131 |
| abstract_inverted_index.Figure | 188 |
| abstract_inverted_index.assay. | 130 |
| abstract_inverted_index.caused | 361 |
| abstract_inverted_index.cohort | 52 |
| abstract_inverted_index.common | 9 |
| abstract_inverted_index.delay, | 32 |
| abstract_inverted_index.during | 17, 138, 351 |
| abstract_inverted_index.either | 106 |
| abstract_inverted_index.entire | 89 |
| abstract_inverted_index.higher | 177 |
| abstract_inverted_index.infant | 35 |
| abstract_inverted_index.levels | 375 |
| abstract_inverted_index.lowest | 191 |
| abstract_inverted_index.months | 114, 255, 267, 274, 299, 327, 412 |
| abstract_inverted_index.points | 56 |
| abstract_inverted_index.report | 38 |
| abstract_inverted_index.sample | 102 |
| abstract_inverted_index.titers | 169 |
| abstract_inverted_index.total, | 147 |
| abstract_inverted_index.varied | 171 |
| abstract_inverted_index.waning | 242 |
| abstract_inverted_index.which, | 357 |
| abstract_inverted_index.>99% | 155 |
| abstract_inverted_index.(Figure | 239 |
| abstract_inverted_index.African | 201 |
| abstract_inverted_index.Between | 63 |
| abstract_inverted_index.Methods | 62 |
| abstract_inverted_index.Results | 145 |
| abstract_inverted_index.between | 263, 372 |
| abstract_inverted_index.cohort. | 90 |
| abstract_inverted_index.highest | 213, 222 |
| abstract_inverted_index.infancy | 18 |
| abstract_inverted_index.infants | 157, 228, 281, 395 |
| abstract_inverted_index.overall | 176 |
| abstract_inverted_index.period; | 355 |
| abstract_inverted_index.present | 391 |
| abstract_inverted_index.prevent | 34 |
| abstract_inverted_index.results | 233 |
| abstract_inverted_index.studied | 72 |
| abstract_inverted_index.through | 57 |
| abstract_inverted_index.~2-fold | 261 |
| abstract_inverted_index.~3-fold | 249 |
| abstract_inverted_index.18-month | 334 |
| abstract_inverted_index.Abstract | 0 |
| abstract_inverted_index.Authors: | 421 |
| abstract_inverted_index.Canadian | 209 |
| abstract_inverted_index.Dramatic | 241 |
| abstract_inverted_index.Funding. | 415 |
| abstract_inverted_index.analyzed | 119 |
| abstract_inverted_index.anti-RSV | 26 |
| abstract_inverted_index.antibody | 28, 168 |
| abstract_inverted_index.assigned | 97 |
| abstract_inverted_index.children | 94 |
| abstract_inverted_index.country, | 173 |
| abstract_inverted_index.detected | 306 |
| abstract_inverted_index.enrolled | 151 |
| abstract_inverted_index.evident, | 246 |
| abstract_inverted_index.followed | 153 |
| abstract_inverted_index.identify | 136 |
| abstract_inverted_index.infants, | 313 |
| abstract_inverted_index.newborns | 67, 149, 202, 210 |
| abstract_inverted_index.observed | 324 |
| abstract_inverted_index.provided | 229 |
| abstract_inverted_index.randomly | 96 |
| abstract_inverted_index.reported | 423 |
| abstract_inverted_index.Geometric | 166 |
| abstract_inverted_index.Hondurans | 219 |
| abstract_inverted_index.collected | 84, 103, 198 |
| abstract_inverted_index.countries | 70 |
| abstract_inverted_index.different | 54 |
| abstract_inverted_index.follow-up | 141, 230 |
| abstract_inverted_index.infection | 378 |
| abstract_inverted_index.reported. | 144 |
| abstract_inverted_index.subcohort | 92, 238 |
| abstract_inverted_index.syncytial | 3 |
| abstract_inverted_index.Background | 1 |
| abstract_inverted_index.Conclusion | 382 |
| abstract_inverted_index.additional | 260 |
| abstract_inverted_index.attenuate, | 31 |
| abstract_inverted_index.countries, | 398 |
| abstract_inverted_index.detectable | 159 |
| abstract_inverted_index.identified | 350 |
| abstract_inverted_index.infection. | 36 |
| abstract_inverted_index.infections | 15 |
| abstract_inverted_index.presented. | 381 |
| abstract_inverted_index.previously | 143 |
| abstract_inverted_index.worldwide. | 19 |
| abstract_inverted_index.Biologicals | 417 |
| abstract_inverted_index.Disclosures | 419 |
| abstract_inverted_index.Respiratory | 2 |
| abstract_inverted_index.respiratory | 13 |
| abstract_inverted_index.Associations | 371 |
| abstract_inverted_index.Disclosures. | 424 |
| abstract_inverted_index.Neutralizing | 383 |
| abstract_inverted_index.neutralizing | 27 |
| abstract_inverted_index.surveillance | 132 |
| abstract_inverted_index.prospectively | 73 |
| abstract_inverted_index.respectively. | 314, 343 |
| abstract_inverted_index.(NCT01995175). | 81 |
| abstract_inverted_index.concentrations | 24, 44, 126 |
| abstract_inverted_index.neutralization | 129 |
| abstract_inverted_index.GlaxoSmithKline | 416 |
| cited_by_percentile_year | |
| countries_distinct_count | 8 |
| institutions_distinct_count | 23 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.6200000047683716 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.17933802 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |